Variable Number of Tandem Repeats of TNF Receptor Type 2 Promoter as Genetic Biomarker of Susceptibility to Develop Invasive Pulmonary Aspergillosis

Human Immunology

Volumn 68, Issue 1, 2007, Pages 41-50

  Sainz, Juan ^a   Pérez, Eva ^a   Hassan, Laila ^a   Moratalla, Antonio ^a   Romero, Antonio ^a   Collado, María Dolores ^a   Jurado, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Invasive Pulmonary Aspergillosis; LT ; susceptibility; TNF ; TNFR2 polymorphisms

Indexed keywords

GALACTOMANNAN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; LUNG ASPERGILLOSIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ASPERGILLOSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; MINISATELLITE REPEATS; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 33845882479     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.011     Document Type: Article

References (61)

1. Wingard J.R. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 5 (1999) 55
2. Saugier-Veber P., Devergie A., Sulahian A., Ribaud P., Traore F., Bourdeau-Esperou H., Gluckman E., and Derouin F. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant 12 (1993) 121
3. Clark T.A., and Hajjeh R.A. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15 (2002) 569
4. Gerson S.L., Talbot G.H., Hurwitz S., Strom B.L., Lusk E.J., and Cassileth P.A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann Intern Med 100 (1984) 345
5. Fleming R.V., Walsh T.J., and Anaissie E.J. Emerging and less common fungal pathogens. Infect Dis Clin North Am 16 (2002) 915
6. Weinberger M., Elattar I., Marshall D., Steinberg S.M., Redner R.L., Young N.S., and Pizzo P.A. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine 71 (1992) 24
7. Aisner J., Murillo J., Schmipff S.C., and Steere A.C. Invasive aspergillosis in acute leukaemia: correlation with nose cultures and antibiotics use. Ann Intern Med 90 (1979) 4
8. Palmer L.B., Greenberg H.E., and Schiff M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46 (1991) 15
9. Taramelli D., Malabarba M.G., Basilico N., Sala G., Mattina R., and Cocuzza C. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J Med Vet Mycol 34 (1996) 49
10. Dofferhoff A.S., Esselink M.T., de Vries-Hospers H.G., van Zanten A., Bom V.J., Weits J., and Vellenga E. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 31 (1993) 373
11. Marks J.D., Marks C.B., Luce J.M., Montgomery A.B., Jurner J., Mertz C.A., and Murray J.F. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141 (1990) 94
12. de la Mata M., Meager A., Rolando N., Daniels H.M., Nouri-Aria K.T., Goka A.K., Eddleston A.L., Alexander G.J., and Williams R. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 82 (1990) 479
13. Gimenez F., Barraud de Lagerie S., Fernández C., Pino P., and Mazier D. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 60 (2003) 1623
14. Allendoerfer R., Magee D.M., Smith J.G., Bonewald L., and Graybill J.R. Induction of tumor necrosis factor-α in murine Candida albicans infection. J Infec Dis 167 (1993) 1168
15. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717
16. Gruss H.J. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 26 (1996) 143
17. Gosselin D., DeSanctis J., Boule M., Skamene E., Matouk C., and Radzioch D. Role of tumor necrosis factor a in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 63 (1995) 3272
18. Laichalk L.L., Kunkel S.L., Strieter R.M., Danforth J.M., Bailie M.B., and Standiford T.J. Tumor necrosis factor mediates lung antibacterial host defence in murine Klebsiella pneumonia. Infect Immun 64 (1996) 5211
19. Moussa K., Michie H.J., Cree I.A., McCafferty A.C., Winter J.H., Dhillon D.P., Stephens S., and Brown R.A. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49 (1994) 107
20. Cenci E., Mencacci A., Fe d'Ostiani C., Del Sero G., Mosci P., Montagnoli C., Bacci A., and Romani L. Cytokine and T-helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 178 (1998) 1750
21. Cenci E., Perito S., Enssle K.H., Mosci P., Latge J.P., Romani L., and Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 65 (1997) 564
22. Cenci E., Mencacci A., Fe d'Ostiani C., Montagnoli C., Bacci A., Del Sero G., Perito S., Bistoni F., and Romani L. Cytokine and T-helper-dependent immunity in murine aspergillosis. Res Immunol 149 (1998) 445
23. Brieland J.K., Jackson C., Menzel F., Loebenberg D., Cacciapuoti A., Halpern J., Hurst S., Muchamuel T., Debets R., Kastelein R., Churakova T., Abrams J., Hare R., and O'Garra A. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 3 (2001) 1554
24. Mehrad B., Strieter R.M., and Standiford T.J. Role of TNF-alpha in pulmonary host defence in murine invasive aspergillosis. J Immunol 162 (1999) 1633
25. Vonk A.G., Netea M.G., van Krieken J.H., van der Meer J.W.M., and Kullberg B.J. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-α- and lymphotoxin-α-deficient mice. J Infect Dis 186 (2002) 1815
26. Netea M.G., van Tits L.J., Curfs J.H., Amiot F., Meis J.F., van der Meer J.W., and Kullberg B.J. Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163 (1999) 1498
27. Steinshamn S., Bemelmans M.H., Van Tits L.J., Bergh K., Buurman W.A., and Waage A. TNF receptors in murine Candida Albicans infection: evidence for an important role of TNF receptor p55 in antifungal defence. J Immunol 157 (1996) 2155
28. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., and McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: prevalence to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87 (1990) 1233
29. Wilson A.G., de Giovine F.S., and Duff G.W. Genetics of TNF-α in autoimmune, infectious and neoplastic diseases. J Inflamm 45 (1995) 1
30. de Jong B.A., Westendorp R.G.J., Bakker A.M., and Huizinga T.W.J. Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production. Genes Immunity 3 (2002) 25
31. Pociot F., Briant L., Jongeneel C.V., Molvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., and Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23 (1993) 224
32. Al-Ansari A.S., Ollier W.E., Villareal J., Oridi J., Teh L.S., and Hajeer A.H. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 55 (2000) 97
33. Keen L., Wood N., Olomolaiye O., and Bidwell J. A bi-allelic VNTR in the human TNFR2 (p75) gene promoter. Genes Immun 1 (1999) 164
34. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., Denning D.W., Donnelly J.P., Edwards J.E., Erjavec Z., Fiere D., Lortholary O., Maertens J., Meis J.F., Patterson T.F., Ritter J., Selleslag D., Shah P.M., Stevens D.A., and Walsh T.J. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7
35. Paterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 123
36. Levitz S., Selsted M.E., Ganz T., Lehrer R.I., and Diamond R.D. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 154 (1986) 483
37. Schaffner A., Douglas H., and Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 69 (1982) 617
38. Waldorf A.R., Levitz S., and Diamond R.D. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 150 (1984) 752
39. Netea M.G., Blok W.L., Kullberg B.J., Bemelmans M., Vogels M.T.E., Buurman W.A., and Van der Meer J.W.M. Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 171 (1995) 393
40. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., and Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113 (1998) 401
41. Wilson A.G., Symons J.A., McDowell T.L., di Giovine F.S., and Duff G.W. Effects of a polymorphism in human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195
42. O'Keefe G.E., Hybki D.L., and Munford R.S. The G→A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 52 (2002) 817
43. Mcguire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., and Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508
44. Messer G., Spengler U., Jung M.C., Honold G., Blomer K., Pape G.R., Riethmuller G., and Weiss E.H. Polymorphic structure of the TNF locus: an Nco I polymorphism in the first intron of the human TNF-β correlates with a variant amino-acid in position 26 and reduced levels of the TNF-β production. J Exp Med 173 (1991) 209
45. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., and Tanaka T. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32 (2002) 650
46. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381
47. Lanas A., Garcia-Gonzalez M.A., Santolaria S., Crusius J.B., Serrano M.T., Benito R., and Pena A.S. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun 2 (2001) 415
48. Tartaglia L.A., Pennica D., and Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268 (1993) 18542
49. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., and Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160 (1998) 943
50. Netea M.G., Van Tits L.J., Curfs J.H., Amiot E., Meis J.F., Van Der Meer J.W., and Kullber G.B.J. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163 (1999) 1498
51. Wild G., and Rioux J.D. Genome scan analyses and positional cloning strategy in IBD: successes and limitations. Baillieres Best Pract Res Clin Gastroenterol 18 (2004) 541
52. Komata T., Tsuchiya N., Matsushita M., Hagiwara K., and Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 53 (1999) 527
53. Barton A., John S., Ollier W.E.R., Silman A., and Worthington J. Polymorphism of the tumor necrosis factor-receptor 2 (TNFR2) but not TNFR1 is associated with rheumatoid arthritis. Arthritis Rheum 44 (2001) 61
54. Phadke A.P., and Mehrad B. Cytokines in host defense against Aspergillus fumigatus: recent advances. Med Mycol 43 (2005) S173
55. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., and Walsh T.J. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 66 (1998) 5999
56. Diamond R.D., Lyman C.A., and Wysong D.R. Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J Clin Invest 87 (1991) 711
57. Ferrante A., Nandoskar M., Walz A., Goh D.H.B., and Kowanko I.C. Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Appl Immunol 86 (1988) 82
58. Shalaby M.R., Palladino M.A., Hirabayashi S.E., Eessalu T.E., Lewis G.D., Shepard H.M., and Aggarwal B. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol 41 (1987) 196
59. Perussia B., Kobayashi M., Rossi M.E., Anegon I., and Trinchieri G. Immune interferon enhances properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol 138 (1987) 765
60. Arathoon E.G. Clinical efficacy of echinocandin antifungals. Curr Opin Infect Dis 14 (2001) 685
61. Ullman A.J. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin 19 (2003) 263